Complex Swiss consultation threatens stem cell law
This article was originally published in Clinica
A consultation process launched by the Swiss government has ended with a majority decision in favour of pursuing embryonic stem cell research. However, the results - which were submitted by the federal court, a number of political parties, cantonal governments, affected associations and other interested bodies and companies - are not quite as conclusive as pro-research campaigners may have hoped.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.